Skip to main content

Versartis widens losses

Versartis Inc. (Nasdaq: VSAR) widened third quarter losses more than expected. Shares of the biopharmaceutical lost 40 cents to close at $1.90.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.